Clinical Trial Update: Cerebrolysin in Critically Ill Patients With Delirium [NA]

View source ↗

Summary

This clinical trial update reports that Cerebrolysin is being studied in critically ill patients with delirium and is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Delirium

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Medical University of Lublin | Conditions: Cognitive Impairment | NA | Status: ENROLLING_BY_INVITATION